Mashhad University Scientists Produce New Drug for Cancer
TEHRAN (FNA)- Iranian scientists at Mashhad University of Medical Sciences produced a new medicine to be used for treatment of tumors, specially in prostate cancer.
"Lutetium drug radiates beta rays and given the good features and qualities of the drug, it is used to treat different tumors," Kamran Ariana, a faculty member of Mashhad University of Medical Sciences, said .
He added that the drug is at present used to treat refractory prostate cancer, noting that it acts like hormones, enters the cell and gets attached to the tumor receptors.
Ariana said that the Iran-made medicine has been so far used to treat 42 patients, adding that it prolonged their life and in some cases, destroyed the tumor.
Iran has taken wide strides in science and technology, particularly in medical and medicinal fields, in recent years.
Iranian scientists in January 2013 developed the country’s first anti-cancer drug using nanotechnology.
"The first anti-cancer medicine was produced in Iran,” Head of the Public Relations of the Presidential Office’s Technological Cooperation Department Amir Khanian said.
He also said that the Iranian scientists have produced 18 biotech drugs and are carrying out research on another 29 biotech medicines.
The country has already mass-produced Doxorubicin - a non-carcinogenic drug - used in lung and breast cancer cases and made based on nano-liposomes technique. The drug with higher efficiency needs lower times for use and naturally lessens side effects, including vascular and heart complications.
Iran has also produced two other non-carcinogenic medicines Paclitaxel for breast and ovarian cancer and oxaliplatin for colon cancer.
"Lutetium drug radiates beta rays and given the good features and qualities of the drug, it is used to treat different tumors," Kamran Ariana, a faculty member of Mashhad University of Medical Sciences, said .
He added that the drug is at present used to treat refractory prostate cancer, noting that it acts like hormones, enters the cell and gets attached to the tumor receptors.
Ariana said that the Iran-made medicine has been so far used to treat 42 patients, adding that it prolonged their life and in some cases, destroyed the tumor.
Iran has taken wide strides in science and technology, particularly in medical and medicinal fields, in recent years.
Iranian scientists in January 2013 developed the country’s first anti-cancer drug using nanotechnology.
"The first anti-cancer medicine was produced in Iran,” Head of the Public Relations of the Presidential Office’s Technological Cooperation Department Amir Khanian said.
He also said that the Iranian scientists have produced 18 biotech drugs and are carrying out research on another 29 biotech medicines.
The country has already mass-produced Doxorubicin - a non-carcinogenic drug - used in lung and breast cancer cases and made based on nano-liposomes technique. The drug with higher efficiency needs lower times for use and naturally lessens side effects, including vascular and heart complications.
Iran has also produced two other non-carcinogenic medicines Paclitaxel for breast and ovarian cancer and oxaliplatin for colon cancer.